Clinical trial

Effects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular Hypertrophy

NCT01188369

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2010-09-01

PhasePHASE4

Study timeline

Study start (unknown)2010-09-01Date precision: month

Registry last updated2018-12-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diastolic Dysfunctionunresolved

Left Ventricular Hypertrophyunresolved

Interventions

levosimendanDRUG

placebo drugDRUG

Sponsors & collaborators

University of Aarhuslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01188369 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.